Login to MyKarger

New to MyKarger? Click here to sign up.



Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Original Paper

Protective Effects of Ulinastatin on Proliferation and Cytokine Release of Splenocytes from Rats with Severe Acute Pancreatitis

Ma T. · Kang C. · Shao H. · Qi Q. · Hu W.

Author affiliations

Department of Surgery, General Hospital of the Tianjin Medical University, Tianjin, China

Related Articles for ""

Eur Surg Res 2006;38:445–450

Do you have an account?

Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



Login Information





Contact Information










I have read the Karger Terms and Conditions and agree.



To view the fulltext, please log in

To view the pdf, please log in

Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!

If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.
Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00


Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select

* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 23, 2006
Accepted: June 21, 2006
Published online: October 23, 2006
Issue release date: October 2006

Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 0

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR

Abstract

Aim: To clarify the contributions of ulinastatin to cellular immune responses in vivo, we examined the functional alterations of splenocytes and quantitatively evaluated the effects of ulinastatin on the splenocyte function during experimental severe acute pancreatitis. Methods: Severe acute pancreatitis was induced in rats by retrograde injection of 3% sodium deoxycholate. Thirty minutes after induction of pancreatitis, the rats were randomly assigned to four groups, receiving either saline or 50,000 U/kg of ulinastatin, respectively. Splenocytes were obtained aseptically and stimulated with concanavalin A for 24 h. Then the proliferative activity of cultured splenocytes was measured by using an MTT cellular proliferation assay, and the cytokine concentrations in the culture supernatants were measured by enzyme-linked immunosorbent assays. Results: Upon stimulation, the release of interleukin-2, interleukin-10, and interferon-γ was significantly decreased in the splenocytes from rats with pancreatitis as compared with those from sham operation and control groups. The splenocyte proliferation was also significantly suppressed in this group. In contrast, the proliferative as well as the cytokine-releasing capacities of the splenocytes from rats treated with ulinastatin were significantly increased as compared with those from rats with pancreatitis. Conclusions: The deficiencies in proliferation and cytokine release in response to antigen stimulation demonstrated an anergic state of splenocytes during severe acute pancreatitis. Treatment with ulinastatin contributed to the recovery of the immune function by improving proliferative responses and cytokine release of splenocytes. These data suggest that a protease-modulating therapy may be an effective strategy for the treatment of immunosuppression induced by severe acute pancreatitis.

© 2006 S. Karger AG, Basel


References

  1. Bhatia M, Wong FL, Cao Y, Lau HY, Huang J, Puneet P, Chevali L: Pathophysiology of acute pancreatitis. Pancreatology 2005;5:132–144.
  2. Pandol SJ: Acute pancreatitis. Curr Opin Gastroenterol 2005;21:538–543.
  3. Malangoni MA, Martin AS: Outcome of severe acute pancreatitis. Am J Surg 2005;189:273–277.
  4. Takeyama Y: Significance of apoptotic cell death in systemic complications with severe acute pancreatitis. J Gastroenterol 2005;40:1–10.
  5. Uehara S, Gothoh K, Handa H, Tomita H, Tomita Y: Immune function in patients with acute pancreatitis. J Gastroenterol Hepatol 2003;18:363–370.
  6. Takeyama Y, Takas K, Ueda T, Hori Y, Goshima M, Kuroda Y: Peripheral lymphocyte reduction in severe acute pancreatitis is caused by apoptotic cell death. J Gastrointest Surg 2000;4:379–387.
  7. Chen SY, Wang JY; Shanghai Collaboration Group on Ulinastatin Clinical Trials: Ulinastatin in the treatment of acute pancreatitis: a multicenter clinical trial. Chin J Dig Dis 2001;21:293–296.
  8. Tsujino T, Komatsu Y, Isayama H, Hirano K, Sasahira N, Yamamoto N, Toda N, Ito Y, Nakai Y, Tada M, Matsumura M, Yoshida H, Kawabe T, Shiratori Y, Omata M: Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial. Clin Gastroenterol Hepatol 2005;3:376–383.
  9. Molor-Erdene P, Okajima K, Isobe H, Uchiba M, Harada N, Shimozawa N, Okabe H: Inhibition of lipopolysaccharide-induced tissue factor expression in monocytes by urinary trypsin inhibitor in vitro and in vivo. Thromb Haemost 2005;94:136–145.
  10. Ito K, Mizutani A, Kira S, Mori M, Iwasaka H, Noguchi T: Effect of ulinastatin, a human urinary trypsin inhibitor, on the oleic acid-induced acute lung injury in rats via the inhibition of activated leukocytes. Injury 2005;36:387–394.
  11. Inoue K, Takano H, Shimada A, Yanagisawa R, Sakurai M, Yoshino S, Sato H, Yoshikawa T: Urinary trypsin inhibitor protects against systemic inflammation induced by lipopolysaccharide. Mol Pharmacol 2005;67:673–680.
  12. Sato N, Endo S, Kimura Y, Ikeda K, Aoki K, Iwaya T, Akiyama Y, Noda Y, Saito K: Influence of a human protease inhibitor on surgical stress induced immunosuppression. Dig Surg 2002;19:300–305.
  13. Miki S, Takeyama N, Tanaka T, Nakatani T: Immune dysfunction in endotoxicosis: role of nitric oxide produced by inducible nitric oxide synthase. Crit Care Med 2005;33:716–720.
  14. Schwacha MG, Holland LT, Chaudry IH, Messina JL: Genetic variability in the immune-inflammatory response after major burn injury. Shock 2005;23:123–128.
  15. Matsutani T, Anantha Samy TS, Kang SC, Bland KI, Chaudry IH: Mouse genetic background influences severity of immune responses following trauma-hemorrhage. Cytokine 2005;30:168–176.
  16. Yasuda T, Takeyama Y, Ueda T, Takase K, Nishikawa J, Kuroda Y: Splenic atrophy in experimental severe acute pancreatitis. Pancreas 2002;24:365–372.
  17. Curley P, Nestor M, Collins K, Saporoschetz I, Mendez M, Mannick JA, Rodrick ML: Decreased interleukin-2 production in murine acute pancreatitis: potential for immunomodulation. Gastroenterology 1996;110:583–588.
  18. Shao H, Qi Q: A study on the relationship between acute pancreatitis and apoptosis of the acinar cells. Chin J Gen Surg 2003;18:23–24.
  19. Antal L, Szabo G, Sonkoly S, Paloczi K, Szegedi G: Abnormalities in humoral and cellular immunoactivity in pancreatitis. II. Study of the cellular immune system. Acta Med Acad Sci Hung 1978;35:81–87.
  20. Christophi C, McDermott F, Hughes ES: Prognostic significance of absolute lymphocyte count in acute pancreatitis. Am J Surg 1985;150:295–296.
  21. Ueda T, Takeyama Y, Yasuda T, Takase K, Nishikawa J, Kuroda Y: Functional alterations of splenocytes in severe acute pancreatitis. J Surg Res 2002;102:161–168.
  22. Ueda T, Takeyama Y, Kuroda Y: Animal experimental models for acute pancreatitis. Nippon Rinsho 2004;62:1984–1988.
    External Resources
  23. Ayala A, Chung CS, Song GY, Chaudry IH: IL-10 mediation of activation-induced TH1 cell apoptosis and lymphoid dysfunction in polymicrobial sepsis. Cytokine 2001;14:37–48.
  24. Guo Z, Kavanagh E, Zang Y, Dolan SM, Kriynovich SJ, Mannick JA, Lederer JA: Burn injury promotes antigen-driven Th2-type responses in vivo. J Immunol 2003;171:3983–3990.
  25. Zaitsu M, Hamasaki Y, Tashiro K, Matsuo M, Ichimaru T, Fujita I, Tasaki H, Miyazaki S: Ulinastatin, an elastase inhibitor, inhibits the increased mRNA expression of prostaglandin H2 synthase-type 2 in Kawasaki disease. J Infect Dis 2000;181:1101–1109.
  26. Okuhama Y, Shiraishi M, Higa T, Tomori H, Taira K, Mamadi T, Muto Y: Protective effects of ulinastatin against ischemia-reperfusion injury. J Surg Res 1999;82:34–42.
  27. Inoue K, Takano H, Yanagisawa R, Sakurai M, Shimada A, Yoshino S, Sato H, Yoshikawa T: Protective role of urinary trypsin inhibitor in acute lung injury induced by lipopolysaccharide. Exp Biol Med (Maywood) 2005;230:281–287.
  28. Hirano T, Manabe T, Tobe T: Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats. Dig Dis Sci 1993;38:660–664.
  29. Ohnishi H, Kosuzume H, Ashida Y, Kato K, Honjo I: Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig Dis Sci 1984;29:26–32.
  30. Chen H, Zhou H, Fu H: Experimental study on combined use of sodium aescinate and ulinastatin in treatment of acute pancreatitis in rats. Chin J TCM WM Crit Care 2006;13:51–53.
  31. Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T: Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004;16:1287–1293.
  32. Bassi C, Falconi M, Caldiron E, Salvia R, Sartori N, Butturini G, Contro C, Marcucci S, Casetti L, Pederzoli P: Assessment and treatment of severe pancreatitis. Protease inhibitor. Digestion 1999;60(suppl 1):5–8.
  33. Zhang XQ, Sun JL, Chen YJ, Ma R, Fan XH, Sun JZ: Amelioration of ischemia-reperfusion injury of transplanted small intestine by ulinastatin: effects on accumulation and adhesion of neutrophil. Transplant Proc 2005;37:4464–4466.
  34. Yamaguchi Y, Ohshiro H, Nagao Y, Odawara K, Okabe K, Hidaka H, Ishihara K, Uchino S, Furuhashi T, Yamada S, Mori K, Ogawa M: Urinary trypsin inhibitor reduces C-X-C chemokine production in rat liver ischemia/reperfusion. J Surg Res 2000;94:107–115.
  35. Fries E, Blom AM: Bikunin – not just a plasma proteinase inhibitor. Int J Biochem Cell Biol 2000;32:125–137.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Received: January 23, 2006
Accepted: June 21, 2006
Published online: October 23, 2006
Issue release date: October 2006

Number of Print Pages: 6
Number of Figures: 4
Number of Tables: 0

ISSN: 0014-312X (Print)
eISSN: 1421-9921 (Online)

For additional information: https://www.karger.com/ESR


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.